Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation -: MMF, a new option in GvHD prophylaxis.

被引：0
|
作者：
Kiehl, MG
Linck, D
Schaefer-Eckart, K
Kroeger, M
Bronhaeuser, M
Blau, IW
Wandt, H
Jenke, A
Kienast, J
Armstrong, VW
Basara, N
Schroeder, H
Kraut, L
Fauser, AA
机构：
[1] Clin Hematol Oncol, BMT Unit, Idar Oberstein, Germany
[2] Clin Hematol Oncol, BMT Unit, Nurnberg, Germany
[3] Univ Hosp Munster, Clin Hematol Oncol, Munster, Germany
[4] Univ Hosp Dresden, Dept Hematol Oncol, Dresden, Germany
[5] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Hematol Oncol, D-12200 Berlin, Germany
[6] Univ Hosp Gottingen, Dept Clin Chem, Gottingen, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2650
引用
收藏
页码：716A / 716A
页数：1
相关论文
共 50 条
  • [1] Mycophenolate mofetil in combination with cyclosporine-A (CsA) prednisolone - the new standard for GvHD prophylaxis?
    Linck, D
    Schaefer-Eckardt, K
    Kroeger, M
    Bornhaeuser, M
    Blau, I
    Wandt, H
    Jenke, A
    Kienast, J
    Armstrong, V
    Basara, N
    Schroeder, H
    Fauser, A
    Kiehl, MG
    BONE MARROW TRANSPLANTATION, 2004, 33 : S184 - S185
  • [2] Mycophenolate mofetil and CSA as GVHD prophylaxis after allogeneic blood stem cell transplantation.
    Bornhauser, M
    Thiede, HM
    Schuler, SU
    Thiede, C
    Ehninger, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S117 - S117
  • [3] Intravenous mycophenolate mofetil plus prednisolone and cyclosporine in the prophylaxis of GvHD after stem cell transplantation.
    Kiehl, MG
    Armstrong, V
    Basara, N
    Blau, IW
    Oellerich, M
    Fauser, AA
    BLOOD, 1999, 94 (10) : 153A - 153A
  • [4] Combination of Mycophenolate Mofetil with Cyclosporine A and Methotrexate as Gvhd Prophylaxis In Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation
    Zhu, Xiaoli
    Lai, Xiaoyu
    Luo, Yi
    Shi, Jimin
    Tan, Yamin
    Huang, He
    BLOOD, 2010, 116 (21) : 548 - 548
  • [5] CYCLOSPORINE A IN COMBINATION WITH MYCOPHENOLATE MOFETIL OR METHOTREXATE FOR PROPHYLAXIS OF GVHD
    Duebbers, M.
    Borchert, K.
    Glaeser, D.
    Schmitt, M.
    Junghanss, C.
    Hilgendorf, I.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S285 - S285
  • [6] Impact of adding mycophenolate mofetil (MMF) to cyclosporine (CSA) as prophylaxis for acute graft versus host disease (GVHD) following nonmyeloablative allogeneic peripheral blood stem cell (PBSC) transplantation.
    Chakrabarti, S
    Srinivasan, R
    Geller, N
    Abo-Zena, RA
    Marquesen, M
    Goodwin, R
    Donohue, T
    Dunbar, C
    Young, NS
    Leitman, SF
    Read, EJ
    Bolan, CD
    Barrett, AJ
    Childs, R
    BLOOD, 2002, 100 (11) : 419A - 420A
  • [7] PHARMACODYNAMIC PREDICTION OF GVHD RISK IN REDUCED-INTENSITY CONDITIONING REGIMEN ALLOGENEIC STEM CELL TRANSPLANTATION (RIC ALLOSCT) USING MYCOPHENOLATE MOFETIL (MMF) PLUS CYCLOSPORINE A (CSA) AS GVHD PROPHYLAXIS
    Martinez, C.
    Millan, O.
    Rovira, M.
    Fernandez-Aviles, F.
    Suarez-Lledo, M.
    Urbano-Ispizua, A.
    Brunet, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S283 - S283
  • [8] Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation
    Zhu, Xiaoli
    Lai, Xiaoyu
    Luo, Yi
    Shi, Jimin
    Tan, Yamin
    Zheng, Weiyan
    He, Jingsong
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Ye, Xiujin
    Lin, Maofang
    Cai, Zhen
    Huang, He
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1046 - 1051
  • [9] Comparison of Cyclosporine and Methotrexate with Cyclosporine and Mycophenolate Mofetil for Gvhd Prophylaxis in Myeloablative Allogeneic Bone Marrow Transplantation
    Dean, Robert
    Rybicki, Lisa
    Sobecks, Ronald
    Copelan, Edward
    Kalaycio, Matt
    Andresen, Steven
    Sungren, Shawnda
    Serafin, Mary
    Bolwell, Brian J.
    BLOOD, 2008, 112 (11) : 781 - 781
  • [10] CYCLOSPORINE AND METHOTREXATE (CSA/MTX) COMPARED WITH CYCLOSPORINE AND MYCOPHENOLATE MOFETIL (CSA/MMF) AS GVHD PREVENTION REGIMENS IN ALLOGENEIC STEM-CELL TRANSPLANTATION FROM UNRELATED DONORS; RELATIVE OUTCOMES ARE DEPENDANT ON DISEASE STATUS AT TRANSPLANTATION
    Shimoni, A.
    Shem-Tov, N.
    Rand, A.
    Roth, S.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S328 - S329
12345